home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

A Comparison of ICH Q-10 Quality System and the FDA’s Quality Systems Approach

 
  February 01, 2011  
     
 


ComplianceOnline, Online Event
2011-03-11


NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.  

Why Should You Attend:

The QSA to Pharmaceutical cGMPs and ICH-Q10 are guidance documents that stress the importance of management's responsibilities to meet customer needs by encompassing quality improvement through quality by design QbD), risk management, process control, and user feedback and experience.

This 4 hour course will provide the attendees with the knowledge and insight required to understand and apply the principles and concepts of ICH –Q10 and the Quality Systems Approach. This new paradigm forces industry leaders to rethink their roles in meeting corporate objectives and strategies.

It challenges the FDA to focus on the importance of user requirements and assessing results with less importance on compliance to inflexible rules and regulations. The key message is Senior Management must be actively involved in quality operations because it is they who have the authority and responsibility to control and demand that corrective action be taken to ensure quality issues are addressed openly and effectively.

This course will discuss and analyze the purpose, scope, objectives, and content of this guidance. Similarities and differences will be shown. Graphics and personal experience cases are widely used to explain principles and concepts. Its present enforcement status will be provided. Questions and answers will be highly encouraged.

Course Syllabus:

1.The current quality and regulatory paradigm

  • The FD&C Act established the requirements for safety and effectiveness
  • Current regulations have failed to ensure safety and effectiveness objectives
  • Definition for commonly used terms
  • The battle between compliance and quality
  • Interrelationship between each organizational function and quality
  • The Quality Constitution paves the way to cooperation and teamwork
  • Transforming Juran’s Quality Loop/Spiral to the Regulatory Loop
  • The Pharmaceutical Lifecycle
  • Enforcement Status- FQSA and ICH-Q10

2.Dissecting and Analyzing the FDA’s Quality Systems Approach (FQSA) and ICH-Q10

  • Background
  • Comparison of Scope
  • Comparison of Purpose and Objectives
  • Content and Structure
  • Similarities between FQSA and ICH-Q10
  • Differences between FQSA and ICH-Q10
  • Comparisons to other FDA, ISO, and regional regulations

3.Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulatio

  • CGMPS AND THE CONCEPTS OF MODERN QUALITY SYSTEMS
  • THE QUALITY SYSTEMS MODEL
  • Resources
  • Manufacturing
  • Evaluation Activities

4.ICH-Q10-Pharmaceutical Quality Systems

  • ICH Q10 Objectives
  • MANAGEMENT RESPONSIBILITY
  • CONTINUAL IMPROVEMENT OF PROCESS PERFORMANCE AND PRODUCT QUALITY
  • CONTINUAL IMPROVEMENT OF THE PHARMACEUTICAL QUALITY SYSTEM 

Who Will Benefit:

  • Middle and Senior Management from all functions involved in establishing and executing corporate strategy and objectives
  • Quality, Finance, Sales and Marketing, Operations, Procurement, and Human Resources who have an active or supporting role in Quality
  • Other quality personnel who have the desire and/or potential to advance to quality leadership

 

 
 
Organized by: ComplianceOnline
Invited Speakers:

Howard Cooper, As a consultant, Mr. Cooper shares his 30 years of quality assurance experience in the pharmaceutical and medical device industries by helping smaller companies and startups to understand, develop, and implement GXP quality systems.

He has successfully designed, staffed, and implemented several startup quality systems that resulted in successful product launches. His leadership style motivates personnel to understand the beneficial effect of the GXPs for the company and its employees. He has the ability to assess situations quickly and objectively by finding and focusing on systemic failures.

 
Deadline for Abstracts: 2011-03-11
 
Registration:

Attend Live Online Training

$495.00 One Dial-in One Attendee

$1,299.00 Group–Max. 10 Attendees

(For multiple locations contact Customer Care) 

 

 

E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.